학술논문
The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure
Document Type
Article
Author
Source
In Leukemia Research September 2023 132
Subject
Language
ISSN
0145-2126